| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Malgorzata Mikulska | Q88469748 |
| P2093 | author name string | Małgorzata Mikulska | |
| Elisa Balletto | |||
| P2860 | cites work | ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients | Q27003240 |
| There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy | Q27005826 | ||
| Methicillin-resistant Staphylococcus aureus therapy: past, present, and future | Q27011165 | ||
| Pseudomonas aeruginosa: all roads lead to resistance | Q28240246 | ||
| Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia | Q28302184 | ||
| Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective | Q28388806 | ||
| Outbreak of multi-drug resistant Pseudomonas aeruginosa bloodstream infection in the haematology unit of a South African Academic Hospital | Q28488031 | ||
| Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
| The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies | Q33686940 | ||
| Viridans-group streptococcal infections in immunocompromised hosts | Q33865093 | ||
| Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation | Q33892585 | ||
| Incidence of diarrhea by Clostridium difficile in hematologic patients and hematopoietic stem cell transplantation patients: risk factors for severe forms and death. | Q34040801 | ||
| Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children | Q34157657 | ||
| The Role of Corticosteroids in Adult Respiratory Distress Syndrome caused by Viridans Group Streptococci Bacteremia in Neutropenic Patients | Q34194166 | ||
| Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases | Q34315497 | ||
| How to Manage Infections Caused by Antibiotic Resistant Gram-negative Bacteria - EBMT Educational Meeting from the Severe Aplastic Anaemia and Infectious Diseases Working Parties, Naples, Italy, 2014. | Q41469539 | ||
| Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period | Q41709957 | ||
| Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation | Q42202379 | ||
| Outbreak of Pseudomonas aeruginosa and Klebsiella pneumoniae bloodstream infections at an outpatient chemotherapy center. | Q42208745 | ||
| An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit | Q42220391 | ||
| Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations | Q42234975 | ||
| Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients | Q42237413 | ||
| Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies | Q42558452 | ||
| Molecular epidemiological investigation of an outbreak of Pseudomonas aeruginosa infection in an SCT unit. | Q42599998 | ||
| The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients | Q42831481 | ||
| Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. | Q42968358 | ||
| Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation. | Q43277809 | ||
| Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion. | Q43699491 | ||
| Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study | Q43984868 | ||
| Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients | Q44347574 | ||
| Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes | Q45212684 | ||
| Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection | Q45228197 | ||
| Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies | Q46094551 | ||
| Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance | Q46168121 | ||
| Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens | Q46808811 | ||
| Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus | Q46906478 | ||
| Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections | Q34329633 | ||
| European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia | Q34390823 | ||
| Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms | Q34422182 | ||
| Clostridium difficileinfection in cancer patients and hematopoietic stem cell transplant recipients | Q34624447 | ||
| Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis | Q34728711 | ||
| Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes. | Q34999291 | ||
| Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. | Q35005719 | ||
| Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study | Q35027260 | ||
| Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. | Q35129079 | ||
| Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. | Q35845324 | ||
| Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course | Q36004592 | ||
| Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes | Q36077707 | ||
| Clinical update on linezolid in the treatment of Gram-positive bacterial infections | Q36083208 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation | Q36417501 | ||
| Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation | Q36853960 | ||
| Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027. | Q36856267 | ||
| The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients | Q36895914 | ||
| Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence | Q37147563 | ||
| Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options | Q37150308 | ||
| Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. | Q37250343 | ||
| Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections | Q37263709 | ||
| Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients | Q37946180 | ||
| Fourteen years in resistance | Q37990212 | ||
| Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation | Q38065600 | ||
| Which antibiotic for resistant Gram-positives, and why? | Q38159788 | ||
| Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients | Q38173977 | ||
| Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician | Q38196177 | ||
| Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. | Q38209056 | ||
| Therapeutic options for vancomycin-resistant enterococcal bacteremia. | Q38347869 | ||
| Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy | Q38474339 | ||
| Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center | Q38474817 | ||
| Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp. | Q40170453 | ||
| Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC inf | Q40259251 | ||
| Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection | Q41326035 | ||
| Outbreak of Pseudomonas aeruginosa bacteraemia in a haematology department | Q41335703 | ||
| Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit. | Q51023406 | ||
| Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. | Q51599708 | ||
| Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. | Q51617424 | ||
| Aspergillosis: The most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease. | Q51705733 | ||
| Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation. | Q53584539 | ||
| Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. | Q53636518 | ||
| Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. | Q54346717 | ||
| Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. | Q54373146 | ||
| Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome | Q58814211 | ||
| Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine | Q72175709 | ||
| Pneumonia in allogenic and autologous bone marrow recipients. A retrospective study | Q72852712 | ||
| Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia | Q73445720 | ||
| Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? | Q79290439 | ||
| Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak | Q80034705 | ||
| Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project | Q81640138 | ||
| Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies | Q83419434 | ||
| Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients | Q83958584 | ||
| High incidence of methicillin-resistant Staphylococcus aureus sepsis and death in patients with febrile neutropenia at Royal Darwin Hospital | Q84516931 | ||
| Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci | Q84920715 | ||
| Viridans group streptococci in febrile neutropenic cancer patients: what should we fear? | Q87731541 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | e2015045 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Mediterranean journal of hematology and infectious diseases | Q27723406 |
| P1476 | title | Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients | |
| P478 | volume | 7 |
| Q47554129 | Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients |
| Q30238945 | Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation |
| Q89666162 | Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations |
| Q50119378 | Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients. |
| Q39979048 | Effect of inhaled steroids on laryngeal microflora |
| Q88375312 | Epidemiologic Profile of Patients Transplanted With Hematopoietic Stem Cells in a Reference Service in the State of Rio Grande do Norte, Brazil |
| Q58768125 | Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study |
| Q36913239 | Epidemiology of antimicrobial resistance in bloodstream infections |
| Q92619791 | Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment |
| Q28079606 | Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation |
| Q57818274 | Infection Complications in Hematopoietic Stem Cells Transplant Recipients: Do Genetics Really Matter? |
| Q90684758 | Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group |
| Q47917729 | Risk factors for cefepime nonsusceptible Gram-negative infections in allogeneic hematopoietic cell transplant recipients |
| Q47647385 | Screening for Asymptomatic Clostridium difficile Among Bone Marrow Transplant Patients: A Mixed-Methods Study of Intervention Effectiveness and Feasibility |
| Q57191722 | The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT) |
| Q37619850 | Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies |
Search more.